Notes - Finance Income And Finance Costs

Takeda Pharmaceutical Company Limited - Filing #7251660

Concept 2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
Notes - Finance income and finance costs
Components of finance income and finance costs
Finance income
Interest income
Financial assets measured at amortized cost
16,576,000,000 JPY
8,850,000,000 JPY
Dividend income
Equity instruments designated as measured at fair value through other comprehensive income
344,000,000 JPY
335,000,000 JPY
Other
6,784,000,000 JPY
1,875,000,000 JPY
Finance income
46,549,000,000 JPY
52,093,000,000 JPY
Finance costs
Other
49,665,000,000 JPY
34,096,000,000 JPY
Finance costs
210,065,000,000 JPY
219,850,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.